Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
Democrats said the portfolio included up to $39.1 million in stocks tied to Medicare drug-price exemptions that could raise costs for beneficiaries.
- A report released Friday by the Joint Economic Committee found President Donald Trump's pharmaceutical stock holdings grew from $1.7 million in 2024 to $56.2 million by the end of 2025.
- The growth coincides with a Republican-backed 2025 law that shielded certain medications from Medicare price negotiations through an expanded 'orphan drug' exemption, allowing companies to maintain higher prices.
- Democrats' analysis shows Trump's portfolio purchased up to $2.55 million in pharma shares before he signed the legislation in July 2025, with an additional $1 million in AbbVie stock bought in August.
- Medicare beneficiaries receiving cancer drugs Keytruda and Opdivo could pay roughly $5,000 more annually under these exemptions than if the government had negotiated lower prices for the medications.
- White House spokesperson Davis Ingle denied conflicts of interest, stating the portfolio is independently managed; recent polling shows most Americans believe Trump is profiting from the presidency in unethical ways.
17 Articles
17 Articles
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say – WTOP News
WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from...
Trump increased investments in drugmakers that benefited from Medicare
WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that
The Toronto Star
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a…
Coverage Details
Bias Distribution
- 47% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
